ApprovalTrail

Approval · Notice of Compliance 568 · 2002

ORGALUTRAN: Notice of Compliance 568

Issued May 1, 2002

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
568
Date
May 1, 2002
Company
Organon Canada Inc.Kirkland, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
New Active Substance (NAS)
Therapeutic class
Gonadotropin-releasing hormone (gnrh) antagonist

Products in this notice

BrandDINStatus today
ORGALUTRAN02245641Marketed

Medicinal ingredients